✦ LIBER ✦

NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia

✍ Scribed by Whitney Miller; Joanne Holden; Elisabeth George; Ken Stein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low expression of the putative tumour su

✍ Jacqueline Boultwood; Andrea Pellagatti; Fiona Watkins; Lisa J. Campbell; Noor E 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Platelet doubling after the first azacit

✍ Lieke H. van der Helm; Canan Alhan; Pierre W. Wijermans; Marinus van Marwijk Koo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

P-300 Azacitidine for the treatment of m

✍ Oshikawa, G.; Yasunaga, M.; Umezawa, Y.; Kobayashi, T.; Doki, N.; Kakihana, K.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Alemtuzumab vs ATG for T-Cell Depletion

✍ V.T. Potter; V.J. Tindell; L. Reiff-Zall; A. Ho; M. Kenyon; J. Marsh; A. Pagliuc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Platelet count doubling after the first

✍ Zeidan, Amer M.; Lee, Ju-Whei; Prebet, Thomas; Greenberg, Peter; Sun, Zhuoxin; J 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Azacitidine in the treatment of therapy

✍ Bally, Cecile; Thépot, Sylvain; Quesnel, Bruno; Vey, Norbert; Dreyfus, Francois; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 416 KB